Abbott Shells Out $710M To Expand Heart, Eye Portfolio
Abbott Laboratories expanded its presence in the heart and eye surgery markets Monday, agreeing to pay up to $710 million to take over IDEV Technologies, which manufactures a high-end stent product,...To view the full article, register now.
Already a subscriber? Click here to view full article